Metabolic Profiling Revealed Dysregulated Arachidonic Acid Metabolism and Tryptophan Metabolism in the Lungs from Canines with Pacing-induced Heart Failure

Junhan Zhao, Jing Wang, Shengwen Yang, Ran Jing, Xi Liu, Min Gu, Chi Cai, Hongxia Niu, Shu Zhang, Wei HuaResearch 2020 · DOI

Introduction

Heart failure (HF) remains a significant global health challenge, with lung congestion serving as its primary clinical hallmark. Traditionally, pulmonary congestion in HF has been viewed through a hemodynamic lens—a "plumbing" issue where inefficient cardiac pumping leads to increased pulmonary venous pressure and subsequent fluid extravasation. However, conventional treatments like diuretics and vasodilators often fail to fully resolve congestion, suggesting that underlying biological mechanisms beyond simple pressure dynamics are at play. This study investigates the metabolic signatures of lung tissue during HF to identify potential therapeutic targets that address the biological roots of pulmonary congestion.

Methods

To explore these metabolic shifts, researchers employed a canine model of chronic heart failure. Eleven male beagles were divided into a sham control group and an HF group. Heart failure was induced in the latter group via six weeks of rapid ventricular pacing (250 beats/min). The HF phenotype was validated through echocardiography, which demonstrated a significant reduction in left ventricular ejection fraction (LVEF) and increased ventricular volume, alongside elevated molecular markers such as BNP mRNA levels.

Lung tissues were harvested and analyzed using Ultra-High Performance Liquid Chromatography-Tandem Mass Spectrometry (UHPLC-MS/MS) for untargeted metabolomics. Data preprocessing was conducted using XCMS software, and multivariate statistical analyses, including Principle Component Analysis (PCA) and pathway topology analysis via MetaboAnalyst 4.0, were used to identify dysregulated metabolic pathways.

Results

The study revealed profound metabolic remodeling in the lungs of HF subjects, identifying over 160 significantly dysregulated metabolites (81 in positive ion mode and 80 in negative ion mode). Key findings include:

  • Arachidonic Acid (AA) Metabolism: This was identified as the most significantly disrupted pathway. The researchers observed a marked decrease in protective metabolites such as epoxyeicosatrienoic acids (EETs), specifically 11,12-EET, and prostaglandins (PGE2, PGI2). EETs are known for their anti-inflammatory and vasodilatory properties; their depletion likely contributes to increased vascular permeability and inflammation in the failing lung.
  • Tryptophan-Kynurenine Axis: Tryptophan metabolism was the second most affected pathway. HF lungs showed significantly elevated levels of L-tryptophan, L-kynurenine, and 5-hydroxy-L-tryptophan. These metabolites are associated with endothelial dysfunction and pulmonary hypertension, suggesting a role in the structural damage observed in chronic lung congestion.
  • Enzymatic Malfunction: The data suggests widespread dysfunction across the three primary enzymatic pathways for AA: cyclooxygenase (COX), lipoxygenase (LOX), and cytochrome P-450 (CYP).

Physiological markers confirmed the model's success, with LVEF dropping from approximately 61% in the sham group to 37% in the HF group, accompanied by increased lung weight indicative of fluid retention.

Discussion and Future Directions

These findings shift the paradigm of lung congestion from a passive fluid accumulation process to an active site of metabolic signaling and remodeling. The identification of the AA and tryptophan pathways as central nodes of dysregulation opens new avenues for the management of HF.

While the study is limited by a small sample size and the specific nature of the pacing-induced model, it provides a critical foundation for future research. Subsequent studies should investigate whether pharmacological modulation of these pathways—such as preventing the breakdown of EETs or inhibiting the kynurenine pathway—can provide a "metabolic diuretic" effect to help manage HF patients more effectively than current volume-based therapies.

Summary updated

Abstract

Abstract Background: Lung has critical pathophysiological connections to heart and lung congestion presents one of the hallmark features of heart failure (HF). This study aimed to explore the metabolic signatures and disturbances in lungs under HF condition and provide insights on the pathophysiology of the lungs under HF condition from the perspective of metabolism.Methods: In this study, we established a rapid pacing induced HF canine model and applied a comprehensive untargeted metabolomics method to comparatively assessed the metabolomics profiles in the lung tissues from HF group and sham group. Results: Distinct metabolic signatures were identified in the lungs between beagles in HF group and sham group. 81 dysregulated metabolites were identified as differential metabolites (adjusted P <0.05, FC≥2 or≤0.5) in positive ion mode and 80 dysregulated metabolites in negative ion mode, indicating a profound metabolic alteration in the lungs under HF condition. In pathway analysis, arachidonic acid metabolism and tryptophan metabolism were identified as the most significant dysregulated metabolic pathways in the lungs from HF beagles.Conclusions: In this study, we identified profound metabolic variation and dysregulated metabolic pathways, which may deepen our understanding on the pathophysiology of the lungs under HF condition from the perspective of metabolism and open new avenues in lung congestion management in HF.
BibTeX
@inproceedings{zhao2020metabolic,
  author = {Junhan Zhao and Jing Wang and Shengwen Yang and Ran Jing and Xi Liu and Min Gu and Chi Cai and Hongxia Niu and Shu Zhang and Wei Hua},
  title = {{Metabolic Profiling Revealed Dysregulated Arachidonic Acid Metabolism and Tryptophan Metabolism in the Lungs from Canines with Pacing-induced Heart Failure}},
  booktitle = {Research},
  year = {2020},
  doi = {10.21203/rs.3.rs-96585/v1},
}
Figure